Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04198922
What this trial is testing

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Who this might be right for
Recurrent Moderate-Severe Chronic Graft Versus Host DiseaseHematopoietic and Lymphoid Cell Neoplasm
Fred Hutchinson Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT03990051
What this trial is testing

Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

Who this might be right for
Chronic Ocular Graft-versus-host Disease
Glia, LLC 33
Testing effectiveness (Phase 2)Study completedNCT00423514
What this trial is testing

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Large-scale testing (Phase 3)Active Not RecruitingNCT06263478
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host-disease
Incyte Biosciences Japan GK 21
Large-scale testing (Phase 3)Study completedNCT00031824
What this trial is testing

Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Children's Oncology Group 82
Testing effectiveness (Phase 2)Study completedNCT02749084
What this trial is testing

Multiple Donor Treg DLI for Severe Refractory Chronic GVHD

Who this might be right for
Chronic Graft Versus Host Disease
Mario Arpinati 18
Large-scale testing (Phase 3)Study completedNCT01188798
What this trial is testing

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+2 more
St. Jude Children's Research Hospital 6
Testing effectiveness (Phase 2)UnknownNCT04213248
What this trial is testing

Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD

Who this might be right for
Dry Eye
Zhongshan Ophthalmic Center, Sun Yat-sen University 27
Post-approval studies (Phase 4)Study completedNCT01860183
What this trial is testing

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Who this might be right for
Kidney TransplantationKidney Failure
Clinical Hospital Merkur 76
Testing effectiveness (Phase 2)Study completedNCT00006417
What this trial is testing

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Not applicableStudy completedNCT07271498
What this trial is testing

The Oral cGVHD as a Predictive Factor of Graft Versus Leukaemia Effect in Patients Who Received an Allograft

Who this might be right for
AllograftsOral cGVHD
Centre Hospitalier Universitaire de Nice 93
Not applicableActive Not RecruitingNCT04044365
What this trial is testing

Pediatric cGVHD Symptom Scale

Who this might be right for
Graft vs Host Disease
National Cancer Institute (NCI) 139
Testing effectiveness (Phase 2)Looking for participantsNCT07012304
What this trial is testing

Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy

Who this might be right for
Chronic Graft Versus Host Disease
Yujun DONG 24
Not applicableStudy completedNCT00619879
What this trial is testing

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Who this might be right for
Leukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 81
Large-scale testing (Phase 3)Study completedNCT03474679
What this trial is testing

The Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Graft vs Host Disease
Janssen Pharmaceutical K.K. 19
Testing effectiveness (Phase 2)UnknownNCT03225417
What this trial is testing

Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

Who this might be right for
Hematopoietic Stem Cell TransplantationMultiple Myeloma
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 142
Early research (Phase 1)Not Yet RecruitingNCT07826676
What this trial is testing

Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease

Who this might be right for
Graft vs Host DiseaseMesenchymal Stem Cell Transplantation
Pontifícia Universidade Católica do Paraná 20
Large-scale testing (Phase 3)Study completedNCT00678275
What this trial is testing

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 161
Next Page